Molecular glues are the latest craze in pharma research, but what are they?
February’s announcement that Novo Nordisk was partnering with a biotech developing molecular glues to treat rare diseases was the latest…
All articles by Isaac Hanson
Isaac Hanson
-
-
Japanese patients among least empowered in developed world, study shows
Japanese patients with chronic conditions including cancer, diabetes and MS are significantly less satisfied with care received, and less confident…
-
Another recall: does Philips have a quality control problem?
Multinational electronics and medical device manufacturer Philips has made headlines lately for all the wrong reasons. The recent recall of…
-
Can Elon Musk’s Neuralink be trusted to put chips in your brain?
Billionaire Elon Musk’s brain-computer interface (BCI) company Neuralink successfully completed its first human implant on Sunday (28 January), according to…
-
IRA lawsuits will be vital test of US’ ability to regulate pharma market
Lawsuits brought by a range of pharmaceutical companies including AstraZeneca and J&J against the US Department of Health and Human…
-
Signal: FTC granted injunction to pause IQVIA’s acquisition of Propel Media
The US Federal Trade Commission (FTC) has been granted a temporary injunction against health tech giant IQVIA’s acquisition of digital…
-
Signal: Lilly searches for new obesity drugs in partnership with Fauna Bio
Pharmaceutical giant Eli Lilly and biotech firm Fauna Bio yesterday (21 December) announced a partnership deal to search for new…
-
Signal: Illumina to divest Grail, ending years-long legal battle
Illumina, the embattled diagnostics company at the heart of a years-long antitrust battle over its acquisition of cancer test manufacturer…
-
Signal: US lays out plan to seize govt-funded drug patents to lower cost
The Biden administration has announced plans to allow agencies to use march-in rights to seize patents of government-funded drugs if…
-
Signal: FDA renews Syapse collaboration to use real-world data in oncology
The US Food and Drug Administration (FDA) has renewed a four-year collaboration agreement between its Oncology Center of Excellence and…